1 Ocak 2016 Dergi makalesi Açık Erişim

Kaya, Z.; Caglayan, S.; Akkiprik, M.; Aral, C.; Ozisik, G.; Ozata, M.; Ozer, A.

DataCite XML

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/54609</identifier>
  <creators>
    <creator>
      <creatorName>Kaya, Z.</creatorName>
      <givenName>Z.</givenName>
      <familyName>Kaya</familyName>
    </creator>
    <creator>
      <creatorName>Caglayan, S.</creatorName>
      <givenName>S.</givenName>
      <familyName>Caglayan</familyName>
      <affiliation>Istanbul Medipol Univ, Sch Med, Dept Internal Med, Div Endocrinol &amp; Metab, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Akkiprik, M.</creatorName>
      <givenName>M.</givenName>
      <familyName>Akkiprik</familyName>
      <affiliation>Marmara Univ, Sch Med, Dept Med Biol, Basibuyuk Mah,Maltepe Basibuyuk Yolu Sok 9-1, TR-34854 Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Aral, C.</creatorName>
      <givenName>C.</givenName>
      <familyName>Aral</familyName>
      <affiliation>Namik Kemal Univ, Fac Arts &amp; Sci, Dept Mol Biol, Tekirdag, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Ozisik, G.</creatorName>
      <givenName>G.</givenName>
      <familyName>Ozisik</familyName>
      <affiliation>Zorlu Ctr, Mem Wellness Endocrinol &amp; Metab, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Ozata, M.</creatorName>
      <givenName>M.</givenName>
      <familyName>Ozata</familyName>
      <affiliation>Parc 15 Endocrinol &amp; Metab Clin, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Ozer, A.</creatorName>
      <givenName>A.</givenName>
      <familyName>Ozer</familyName>
      <affiliation>Marmara Univ, Sch Med, Dept Med Biol, Basibuyuk Mah,Maltepe Basibuyuk Yolu Sok 9-1, TR-34854 Istanbul, Turkey</affiliation>
    </creator>
  </creators>
  <titles>
    <title>Impact Of Glucocorticoid Receptor Gene (Nr3C1) Polymorphisms In Turkish Patients With Metabolic Syndrome</title>
  </titles>
  <publisher>Aperta</publisher>
  <publicationYear>2016</publicationYear>
  <dates>
    <date dateType="Issued">2016-01-01</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/54609</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.1007/s40618-015-0409-1</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">Background The metabolic syndrome (MetS) is characterized by a cluster of metabolic factors, including insulin resistance and type-2 diabetes, abdominal obesity, dyslipidemia, hypertension and microalbuminuria. Impaired glucocorticoid receptor (GR) activity also plays an important role in the etiology of MetS. The objective of our study is to evaluate the effects of GR gene polymorphisms (BclI, N363S, TthIII1 and ER22/23EK) in Turkish patients with MetS.</description>
  </descriptions>
</resource>